First isolation of carbapenem-resistant Acinetobacter beijerinckii from an environmental sample

Acta Microbiologica Et Immunologica Hungarica
Júlia RadóSándor Szoboszlay

Abstract

The emergence of opportunistic Acinetobacter spp. in healthcare settings poses a significant threat to public health. The major reasons for nosocomial spread of these species are their abilities to develop and transfer drug resistance against various classes of antibiotics. Considering that Acinetobacter spp. are ubiquitous in nature, can utilize several carbon sources, and reach humans via various pathways, our aim was to obtain information about the environmental strains of this genus. Our first step was to develop and test a multistep isolation procedure based on traditional scientific methods. Antibiotic resistance patterns of the isolated strains were determined, as susceptibility to 12 antibiotics of 7 classes was tested by MIC Test Strip method. Altogether 366 samples (groundwater, surface water, and soil) of 24 sites were investigated and a collection of 37 Acinetobacter isolates was obtained. Among others, clinically important human pathogen Acinetobacter spp., such as A. baumannii, A. johnsonii, and A. gyllenbergii were identified. Three environmental strains were determined as multidrug-resistant including a carbapenem-resistant, hemolytic Acinetobacter beijerinckii strain isolated from a hydrocarbon-contaminated gro...Continue Reading

References

Apr 1, 1991·Clinics in Dermatology·R P Rapini
Jul 1, 1968·Journal of Bacteriology·P Baumann
Jan 1, 1994·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·P K Dhakephalkar, B A Chopade
Apr 1, 1996·Clinical Microbiology Reviews·E Bergogne-Bérézin, K J Towner
Sep 1, 1997·Nucleic Acids Research·S F AltschulD J Lipman
Jun 14, 2003·The Journal of Antimicrobial Chemotherapy·K Kümmerer
Sep 1, 1959·Journal of Bacteriology·J E STEWARTD O SCHISSLER
Feb 1, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Pierre Edouard Fournier, Hervé Richet
May 20, 2008·British Journal of Anaesthesia·J F KarpD K Weiner
Jun 24, 2008·International Journal of Antimicrobial Agents·Helen GiamarellouKyriaki Kanellakopoulou
Jul 16, 2008·Clinical Microbiology Reviews·Anton Y PelegDavid L Paterson
Dec 17, 2008·Diagnostic Microbiology and Infectious Disease·Philip J Turner
Aug 25, 2009·The Journal of Hospital Infection·K J Towner
Jan 6, 2011·Journal of Vision·Tim J Smith, John M Henderson
Aug 24, 2011·Antimicrobial Agents and Chemotherapy·Krisztina M Papp-WallaceRobert A Bonomo
Dec 6, 2011·International Journal of Systematic and Evolutionary Microbiology·Ok-Sun KimJongsik Chun
Mar 31, 2012·International Journal of Antimicrobial Agents·M K O'Shea
May 15, 2012·Diagnostic Microbiology and Infectious Disease·Anne Marie QueenanTodd A Davies
Mar 7, 2014·Advanced Biomedical Research·Purti C TripathiGopal Nandlal Agrawal
Dec 23, 2014·Journal of Environmental Health Science & Engineering·Nandhini PalanisamySudheer Khan
Feb 13, 2016·Frontiers in Microbiology·Ahmad Al AtrouniMarie Kempf
Dec 23, 2016·International Journal of Systematic and Evolutionary Microbiology·Seok-Hwan YoonJongsik Chun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.